Final-Program-ATS-2023-AP.vp

Respiratory Innovation Summit 2023

RIS Co-Chairs

TIM WATKINS, MD, MS Vice President, Clinical Development; Head, Fibrosis & Pulmonary Diseases - Inflammation Therapeutics, Gilead Sciences

CECILIA GONZALO, MBA Partner Oberland Captial

The Respiratory Innovation Summit unites innovators, investors, clinicians and advocacy groups who are leading the charge to create powerful new treatments for deadly and crippling diseases of the lungs and airways. This meeting historically attracts 275+ global leaders representing all facets of the respiratory industry, including representatives from start-ups, business development, venture capital, government, academia and clinical medicine.

Agenda Highlights

KEYNOTE ADDRESS Using the Apple Ecosystem for Health Research Dr. Asha N. Chesnutt, Clinical Specialist, Apple Health Dr. Russell Bowler, Professor of Medicine, National Jewish Health

Dr. Asha N. Chesnutt

Dr. Russell Bowler

Panel Discussions - Venture Capital - Business Development - Biomarkers and Innovation

26 companies and 70 poster presentations

Over 10 hours of networking and collaboration time

Federal agencies presenting at RIS 2023 will include: NHLBI, NCATS, FDA, BARDA and NIH Foundation

We’d also like to thank our Pioneer Sponsor, Boehringer Ingelheim Pharmaceuticals, Inc., for its generous support.

12 ATS 2023 INTERNATIONAL CONFERENCE